Fulgent Genetics Inc. (FLGT)
18.92
0.46 (2.49%)
At close: Apr 23, 2025, 3:59 PM
18.90
-0.11%
After-hours: Apr 23, 2025, 04:30 PM EDT
Fulgent Genetics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|
| Laboratory Services Revenue | 71.74M | 71.03M |
| Laboratory Services Revenue Growth | +1.01% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|
| Non Us Revenue | 13.61M | 415.33M | 25.01M | 12.58M | 9.02M | 8.26M |
| Non Us Revenue Growth | -96.72% | +1560.41% | +98.86% | +39.39% | +9.28% | n/a |
| United States Revenue | 978.98M | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 30.07M | 29.92M | 30.48M | 42.21M | 27.66M | 28.72M | 31.89M | 39.05M | 36.13M | 41.11M | 33.72M | 30.3M | 18.31M | 13.55M | 13.01M | 12.72M | 8.76M | 5.06M | 3.63M | 3.37M | 3.21M | 2.94M | 2.8M | 2.5M | 2.42M | 2.65M | 2.62M | 2.4M | 2.59M | 1.99M | 2.38M | 1.91M | 2.02M | 934K | 2.19M | 3.87M | 496K | 410K | 313K |
| Selling, General, and Administrative Revenue Growth | +0.51% | -1.83% | -27.79% | +52.59% | -3.68% | -9.94% | -18.34% | +8.09% | -12.12% | +21.92% | +11.26% | +65.49% | +35.16% | +4.14% | +2.27% | +45.30% | +73.06% | +39.29% | +7.87% | +4.92% | +9.34% | +4.78% | +11.82% | +3.47% | -8.47% | +1.07% | +9.04% | -7.26% | +29.98% | -16.24% | +24.19% | -5.15% | +116.06% | -57.35% | -43.41% | +680.24% | +20.98% | +30.99% | n/a |
| Research and Development Revenue | 11.78M | 13.49M | 11.43M | 11.95M | 10.01M | 9.69M | 9.78M | 8.51M | 7.51M | 6.91M | 5.99M | 7.46M | 6.02M | 5.31M | 5.42M | 4.58M | 3.18M | 1.85M | 1.98M | 1.79M | 1.74M | 1.57M | 1.42M | 1.43M | 1.44M | 1.21M | 1.46M | 1.32M | 1.13M | 920K | 851K | 818K | 1.5M | 656K | 561K | 3.65M | 311K | 253K | 217K |
| Research and Development Revenue Growth | -12.63% | +17.95% | -4.33% | +19.35% | +3.32% | -0.92% | +14.96% | +13.35% | +8.72% | +15.29% | -19.76% | +23.97% | +13.35% | -2.03% | +18.49% | +44.04% | +71.82% | -6.52% | +10.19% | +2.92% | +10.80% | +10.53% | -0.14% | -0.83% | +18.65% | -16.87% | +10.12% | +17.38% | +22.61% | +8.11% | +4.03% | -45.65% | +129.42% | +16.93% | -84.63% | +1073.31% | +22.92% | +16.59% | n/a |
| Sales and Marketing Revenue | 9.12M | 8.6M | 8.99M | 10.5M | 10.16M | 10.72M | 10.08M | 10.25M | 9.86M | 10.87M | 7.94M | 8.2M | 6.01M | 5.22M | 5.01M | 5.08M | 5.01M | 3.26M | 1.6M | 1.64M | 1.69M | 1.3M | 1.27M | 1.13M | 1.11M | 1.28M | 1.13M | 1.1M | 1.38M | 851K | 891K | 798K | 883K | 477K | 301K | 1.91M | 280K | 243K | 234K |
| Sales and Marketing Revenue Growth | +6.15% | -4.38% | -14.39% | +3.34% | -5.24% | +6.35% | -1.66% | +4.00% | -9.27% | +36.85% | -3.17% | +36.39% | +15.19% | +4.21% | -1.44% | +1.34% | +53.80% | +104.13% | -2.32% | -3.08% | +29.37% | +2.52% | +12.87% | +1.08% | -12.82% | +13.19% | +2.91% | -20.61% | +62.51% | -4.49% | +11.65% | -9.63% | +85.12% | +58.47% | -84.27% | +583.21% | +15.23% | +3.85% | n/a |